China (Mainland)
147027-10-9 in china147027-10-9 147027-10-9on offer CAS NO.147027-10-9
- Min.Order: 1 Kilogram
- Payment Terms: L/C,D/A,D/P,T/T,Other
- Product Details
Keywords
- 147027-10-9 in china
- Lamivudine Intermediate - CME
- 147027-10-9on offer
Quick Details
- ProName: 147027-10-9 in china147027-10-9 147027...
- CasNo: 147027-10-9
- Molecular Formula: C18H27N3O4S
- Appearance: White to off-white powder
- Application: 147027-10-9
- DeliveryTime: up to request
- PackAge: up to request
- Port: Any port in China
- ProductionCapacity: 100 Metric Ton/Year
- Purity: 99%+
- Storage: Store in cool and dry place.
- Transportation: up to request
- LimitNum: 1 Kilogram
Superiority
147027-10-9 in china147027-10-9 147027-10-9on offer
|
SPECIFICATIONS |
RESULTS |
|
|
Appearance |
White crystalline powder |
conform |
|
Purity/Assay |
98.0%min |
99.1% |
|
Molecular Weight |
381.489 |
conform |
Welcome to inquire us to get the certificate of analysis for our Lamivudine intermediate
Lonzeal Pharmaceuticals is drug manufacturer with China/WHO/FDA/ANVISA GMP certificates. We supply pharmaceutical products to esteemed customers globally with high quality, competitive price and good service.
LONZEAL Pharmaceuticals was founded in 2006 and has become a leading manufacturing company covering finished formulation, active pharmaceutical ingredients and advanced intermediates, where ICH guidelines have been strictly applied in the whole chain of R&D, manufacturing process and quality management.
LONZEAL is taking attentiveness and profession to build high quality products, and contributing to health and beautiful life for everyone in the world. The products and manufacturing site of Lonzeal have been approved and inspected by stringent drug authorities such as USFDA, WHO, China NMPA, Brazil ANVISIA and India DCGI, based on which, we have been supplying to esteemed customers globally in the past 15 years with regulatory compliance and good quality.
We have manufacturing site located in Hebei National Biomedical Industrial Zone, FPPs and APIs R&D Center of in Shijiazhuang Hi-tech Development Park, and the commercial office in Beijing, China.
Our current main products cover anti-virus, anti-depression and anti-neuropathic pain areas. Lonzeal has become one of the key manufacturers in the global supply of anti-HIV drugs and is providing support to the treatment need of over 4 Million patients each year worldwide.
Details
About us
LONZEAL Pharmaceuticals is a leading manufacturing company covering finished formulation, active pharmaceutical ingredients and advanced intermediates. Our products and manufacturing site have been approved and inspected by stringent drug authorities such as USFDA, WHO, China NMPA, Brazil ANVISIA and India DCGI, based on which, we have been supplying to esteemed customers globally in the past 15 years with regulatory compliance and good quality.
Our current main products cover anti-virus, anti-depression and anti-neuropathic pain areas. Lonzeal has become one of the key manufacturers in the global supply of anti-HIV drugs and is providing support to the treatment need of over 4 Million patients each year worldwide.